ACH vs USB · rev $10.70B vs P/E 12, rev $28.66B
Accendra Health Inc (ACH) versus U.S. Bancorp (USB) — a side-by-side from cached financials, not a winner call.
Accendra Health Inc (ACH) is a medical distribution company listed on NYSE.
U.S. Bancorp (USB) is a banks - regional company listed on US.
Latest reported ACH revenue for 2024-12-31 was $10.70B. Net income was -$362.7M. Revenue was up 3.6% from 2023-12-31 to 2024-12-31. ACH currently screens at market cap $237.8M.
Latest reported USB revenue for 2025-12-31 was $28.66B. Net income was $7.57B. Revenue was up 4.4% from 2024-12-31 to 2025-12-31. USB currently screens at market cap $74.68B and trailing P/E 11.9.
ACH currently screens at market cap $237.8M. USB currently screens at market cap $74.68B and trailing P/E 11.9.
Not investment advice. Open the ACH and USB stock pages for the full models.
Not investment advice.